Incepta Pharmaceuticals: Background of the company 1
Incepta Pharmaceuticals: Background of the company
1
Human side of the business
Production and Marketing
Accounting and Finance
Business Environment
Prepared by
ID Name9304002 Shabnam Shaolin9304014 Shejoty Mahbub9304138 Md. Sohrab Hossain9304124 Md. Imran Hossain9304104 Omar Faruk9304083 Md. Farhad
Prepared for
Sharmin Shabnam Rahman
Faculty of Business studies
Department of BRAC Business School (BBS)
BRAC University
Dated: 5 August, 2009
5 August, 2009
2
Sharmin Shabnam Rahman
Faculty of Business Studies
Department of BRAC Business School (BBS)
BRAC University
Dear Madam,
Sub: Submission of report for completion of course
This is to inform you that we have completed the report on our current organization, Incepta Pharmaceuticals. The report focuses on the background of the company, human side of the business, production and marketing, accounting and finance, business environment. The report, titled Incepta Pharmaceuticals has been prepared for the completion of the course Business Introduction.
In writing this case, we have followed your instructions for report writing so
as to present our views and understanding in the easiest way. However, we
will be glad to clarify any discrepancy that may arise.
Thank you.
Sincerely,
Acknowledgements
3
ID Name9304002 Shabnam Shaolin9304014 Shejoty Mahbub9304138 Md. Sohrab Hossain9304124 Md. Imran Hossain9304104 Omar Faruk9304083 Md. Farhad
We would like to thank Mr. Asad Uzzaman, Area manager of Incepta
Pharmaceuticals for giving us the opportunity to work with the organization and also
for giving us the privilege to explore the report in writing.
We also want to give thanks to those members of the main branch of Incepta
Pharmaceuticals who help us to completing the report.
Finally, we give thank to our family members, friends for their support and
encouragement. Without their support and encouragement it was not possible to
complete the report.
Executive Summary
This report details about a leading Pharmaceutical company of Bangladesh named
Incepta Pharmaceuticals. The report outlines the background of the company,
4
human side of the business, production and marketing, accounting and finance,
business environment.
Incepta Pharmaceuticals is one of the renowned company in Bangladesh. It starts it
work from1999 and till the company is in the leading position. The company has a
clear vision and its mission is to fulfil their vision. The company has level of
management and these different level managers work together to improve the
present condition of the company. Incepta produces various kinds of medicines and
now the company is exporting medicines to 26 countries. Incepta also maintain
their social responsibilities for the betterment of Bangladesh.
Table of Contents
Page No.
1. Background Of The Company1.1 Introduction 91.2 General Objective 11
5
1.3 Specific Goals 111.4 Scope 121.5 Methodology 121.6 Restrictions and limitations 121.7 Ethics
2. Human side of the business
2.1 Management 13
2.2 Level of management 13
2.3 Organizational structure 14
2.4 Leadership style 15
2.5 Training program 15
3. Products and marketing
3.1 Products of Incepta 16
3.2 List of products 17
3.3 Brief description of some products 21
3.4 Production facilities 27
3.5 Equipment facilities for R&D 28
3.6 Pricing and promotion 28
4. Accounting and finance 29
5. Business environment
5.1 Air pollution 33
5.2 Water pollution 34
5.3 Not to mix up forbidden materials in medicine 35
5.4 Not to sale expired products 35
5.5 Social corporate responsibility 35
6. Conclusion 37
7. Recommendation 38
8. Glossary 39
Table of Illustrations
Page No.
Fig 1 : Head office of Incepta 10
Table 1 : Medicine list of Incepta 17
Fig 2 : Picture of medicine (Actidex) 21
Fig 3: Picture of medicine (Celenta) 24
Fig 4:Prize giving ceremony 30
6
Fig 5: Prize giving ceremony (1) 31
Table 2: Profit and loss account of Incepta 32
Fig 6: Air pollution 33
Fig 7: Water pollution 34
List of Abbreviations
R&D: Research and Development
CSR: Corporate Social Responsibility
VAT: Value Added Tax
SOP: Standard operating Procedures
7
Chapter One
Background of the company
As partial fulfillment of the course Introduction to Business BUS (101), our course
instructor Miss Sharmin Shabnam Rahman had instructed us to write a report on
any aspect of any organization. The report, assigned in 6 July 2009, is due on 5
August 2009.
1.1 Introduction
Incepta Pharmaceuticals Ltd is a leading pharmaceutical company in Bangladesh
established in the year in 1999. The company has a very big manufacturing facility
locating at Savar, 35 kilometer away from the centre of the capital city Dhaka. The
company produces various types of dosage forms which include tablets, capsules,
oral liquids, ampoules, dry powder vials; powder for suspension, nasal sprays etc.
Since its inception, Incepta has been launching new and innovative products in
order to fulfill unmet demand of the medical community. The focus was to bring
more new technologically advanced molecules to this country.
8
Incepta quickly developed a very competent sales team, which promotes the
specialties throughout the country. The company virtually covers every single
corner of the rural as well as urban area of Bangladesh. It has its own large
distribution network having 13 depots all over the country. The company has a clear
vision to become a leading research based dosage from manufacturing company
with global presence within a short period of time.
Incepta began its operation with a handful of highly skilled and dedicated
professionals guided by an able leadership. Proper strategic planning, technical
excellence, swift and timely decisions helped them achieve their objectives leading
to much faster growth. A most dynamic skilled and dedicated marketing team
comprising of pharmacists and doctors are at the core of the marketing operation.
These highly skilled professionals play a crucial role in providing the necessary
strategic guideline for the promotion of its products.
The Researchers and Development department for various dosage forms have been
very well developed. Incepta intends to bring new product of advanced technology
through research hitherto unknown in this country. Such activities will not only
benefit the company but also the total pharmaceutical sector of the company. In the
post 2005 era, the company also intends to embark into the production of Active
Pharmaceuticals Ingredient (API). Plans are underway to get into reverse
9
engineering and analogue research in order to produce new API. Incepta has a clear
vision and the vision is to become a researcher based global pharmaceuticals
company in addition to being a highly efficient generic manufacture. To discover
and develop innovative, value-added products that improves the quality of life of
people around the world and significantly contributes towards the growth of
Bangladesh.
The mission of Incepta Pharmaceuticals is to provide people globally with high
quality health care products at affordable price in order to improve access to
medicine and to provide employees an enabling environment that facilities
realization of their full potential.
1.2 General objective
The general objective of the report is to describe about the background of the
company, human side of the business, production and marketing, accounting and
finance and the business environment of the company.
1.3 Specific goals
The specific goals of this report is to provide a short background of Incepta
Pharmaceuticals, provide a basic understanding about their working system, their
mission and vision and also provide some data about their products.
1.4 Scope
The focus of this report is on Incepta Pharmaceuticals. Only this particular company
has been studied in this report. Other Pharmaceuticals company which are situated
in Bangladesh are not included in this report.
1.5 Methodology
Data collection for the report has employed both primary and secondary sources.
The sources are given below:
10
Primary sources
Interview with the area manager of Incepta Pharmaceuticals
A book from Incepta Pharmaceuticals
Secondary Source
www.inceptapharma.com
1.6 Restrictions and limitations
Being a Business Introduction course the focus of this report is on only some
department’s works of the organization. But the description of each and every
machineries or products is excluded. As we are student we have time limitation to
work for the report. We have also knowledge limitation about the company.
1.7 Ethics
The ethical guidelines in completing this report include transparency and honesty in
carrying out the study, timely data collection and compilation to finish the work
within the deadline.
Chapter Two
Human side of the business
The people of Incepta Pharmaceuticals are the assets of their organization. They are
fundamental to the achievement of their long-term business strategy. The success
11
of Incepta over the years has been due, in large part, to the dedication, skill and
effort of their employees.
2.1 Management
The Management is headed by the Managing Director, the Chief Executive Officer
(CEO) who has been delegated necessary and adequate authority by the Board of
Directors. The Management operates through further delegations of authority at
every echelon of the line management. The Management is responsible for
preparation of segment plans/sub-segment plans for every profit centers with
budgetary targets for every item of goods & services and is held accountable for
deficiencies with appreciation for exceptional performance. These operations are
carried out by the Management through series of committees, sub-committees, ad-
hock committees, standing committees assisting the line management.
2.2 Level of management
Like other organization Incepta has a level of management. In Incepta we found
three types of managers in the level of management. These are: Top level
managers, Middle level managers and First level managers.
The Top-level managers of incepta are: Chief Executive Officer (CEO), Chief
Financial Officer (CFO), Chief Operational Officer (COO), Chief Information Officer
(CIO), and Chairperson of the Board, President, Vice president, and corporate head.
The Middle level managers of Incepta are: General Manager, Plant manager,
Regional manager, and Divisional manager. They are responsible for carrying out
the goals set by top level management. They do so by setting goals for their
departments and other business units. Middle level managers are motivating and
assisting the First level managers to achieve business objectives. Middle level
managers also communicate upward, by offering suggestions and feedback to Top
level managers. Because Middle level managers are more involved in the day-to-
12
day workings of a company, they are providing valuable information to the Top level
managers to help improve the organization's bottom line.
The First level managers of Incepta are: Office manager, Shift supervisor,
Department manager, Foreperson, Crew leader, Store manager. First level
managers are responsible for the daily management of line workers- the employees
who actually produce the product or offer the service. First level managers typically
do not set goals for the organization; they have a very strong influence on the
company. These are the managers that most employees interact with on a daily
basis, and if the managers perform poorly, employees may also perform poorly,
may lack motivation, or may leave the company.
2.3 Organizational structure
Incepta Pharmaceuticals in Bangladesh headquartered at Shantinagar, Dhaka. The
organization also has some branches in Dhaka, while the full services are available
at the head office. The organizational structure of the organization is given below:
Service Quality
Risk and Control
Service Delivery
Human Resources Department
Operations
Legal and Compliance
Finance and Administration
Corporate & External Affairs
2.4 Leadership style
13
In Incepta we found the leadership style is autocratic leadership. In this kind of
leadership the Top level manager plans and makes necessary decisions themselves
and provides detailed instruction to the other members of the organization.
2.5 Training programs
Like other organization Incepta also invests in training and development program to
perform the best of their ability and to develop their careers. They provide job-
related training course for all employees and leadership training for managers.
Medical promotion officers receive detailed training on medicines they promote and
the diseases they are designed to treat. They are given training also on appropriate
marketing practices. Regular refresher courses are held for all sales employees at
least annually. GMP training for factory employees is defined in the specific SOP.
The training needs depend on the functions of the employees. Re-training needs are
identified by realizing inadequate performance on the job, by performance
evaluation. Marketing training programs on brand management, marketing skill
development is conducted by in house personnel and by local training organization.
To ensure marketing and management excellence every year their sales and
marketing employees attend some training programs on Pharmaceuticals marketing
in overseas countries by IMS, Bangladesh.
Chapter Three
Production and marketing
Production and marketing is must for all organization. Producing new products and
sell it to the market is a fundamental work for all organization. Like other
pharmaceuticals company Incepta also has some products and they also have
marketing strategy.
3.1 Products of Incepta Pharmaceuticals14
This company produces medicine in three categories:
Therapeutic Group wise Product list Generic Name wise Product list Trade Name wise Product list
GENERAL PRODUCTS
LIQUID STERILE (Terminally sterilized and aseptically filled ampoule)
SOLID DOSAGE (Capsules, Tablets, Powder)
ORAL LIQUIDS
TOPICAL CREAMS AND OINTMENT
NASAL SPRAY
CEPHALOSPORIN
STERILE POWDER (Aseptically filled vials)
SOLID DOSAGE (Capsules, Tablets, Powder )
3.2 List of products
Analgesic and Anti Inflammatory
Anti Anginal Anti Arrhythmic
ActidexCelentaCortanEdopainEtoracIntafenacIntaflamNalbunNeforex
AngifixFeelnorTrocer
Norbit
15
OricoxPurifenReservixResetReset PlusSalinixTicoflexTopicacinWakoflexWinpain
Anti Coagulant Anti Depressent Anti Epileptic
ParinoxWarin
AmelossArpolaxDuloxenReposeTenaxit
BarbitCarmapineGabapenOxazepPregabenValex
Anti Flatulent Anti Platelet Anti Spasmodic
Lefoam LopirelLopirel Plus
CyclopanDrotapanIribanTimozin
Anti Ulcerant Antibacterial Antidiabetic
CytomisEsonixMarloxNeofastOmenixPantonixRasonix
AdoraBeufloxCefotimeClindacinClindacin creamEcloxEfdinirEmixefExephinFirmacFlamydGatifloxI PenamIncloxIncotimIntamycinIpadox
CompimetConsuconLosuconMefoglipNobesitNomopilPiodar
16
KilbacLevoxinNintoinNitazoxOticlorPedilidProcefSidobacTetrafastTinobacTridosilUltrapimeVanmycinXimeprox
Antiemetic Antifungal Antihistamine
EmenilEmenil PlusOnaseron
Nispore AlervilEncilorFenofexKetomarNeocilorSeasonixSudolorSudorin
Antihypertensive Antimigraine Antipsychotic
AmlosartanAmlotabBenadipCarvistaFixocardIdatixIndaprilLarcadipLitizemOsartilOsartil PlusPeriprilPresonilRamorilRamoril PlusSardopaValsartil
TopirvaZomitan
AripraCyclidFreniaHalopidQuietRopinol
17
Veracal
Antivertigo Anxiolytic and Tranquilliser Bio tech
Menaril DisopanHypnofastLozicumNatsinSiestaZoliumZopilone
EpoetinMaxsulin
Diuretic Drugs for Neuropathy Neuralgia
Fertility & Ovulation Stimulant
AcurenDilastEdeloss and Edeloss Plus
Gynaecological Hepatitis B Medication Herpes Labialis
AloxifLozanaOvuclonUbilon
BarcavirCelbarinLamivirlnfovir
Hormones Irritable Bowel Syndrome Laxative
Doresa AqualaxInolac
Lipid Lowering Mucolytic Expectorant Muscle Relaxant
AdiponilEzetimNicositNofiateTiginorVastocor
AmbolytAquaphenMucolytSudocofTomephen
Somolax
Musculoskeletal Nasal Decongestant Non-narcotic Analgesic
AlurolBonemass DFlexorHyronateJoinix
18
Joinix PlusMyolaxMyolax PlusNodiaReconil
NSAIDs Nutrient Supplements Ophthalmic
AlneedAlneed plusAritone ZAritone ZICalcicarCalvimaxCavic C PlusCavic-CCeegramCompironEvagrenInj. K MMInovit EMecolaginOcarnixOsteo DPrecarePreneedProsol IVProviten A-ZProviten SilverVitabionVitagrowZiflu
AzecolDexagurdDextrobacDilateDNP Eye dropEyebetGatiflox Eye DropI guardIntobacLomequin Eye DropLopadineLubricMastguardMetadaxanMirolastMoxquinTimopress
Other Prokinetic-Antiemetic Respiratory
19
3.3 Brief description of some products
Actidex
Dexketoprofen
Presentation
Actidex : Each tablet contains Dexketoprofen Trometamol equivalent to
Dexketoprofen INN 25 mg.
20
Description
Dexketoprofen belongs to a class of medicines called non-steroidal anti-
inflammatory drugs (NSAIDs). It works by blocking the action of a substance in the
body called cyclo-oxygenase. Cyclo-oxygenase is involved in the production of
chemicals in the body called prostaglandins. Prostaglandins are produced in
response to injury or certain diseases and would otherwise go on to cause swelling,
inflammation and pain. By blocking cyclo-oxygenase, dexketoprofen prevents the
production of prostaglandins and therefore reduces inflammation and pain.
Indications and Uses
Symptomatic treatment of pain of mild or moderate intensity, such as musculo-
skeletal pain, menstrual pain, toothache.
Contraindications
Dexketoprofen tablets are not recommended to use in patients who are-
Allergic to this product or any of its components, aspirin or other non-steroidal anti-
inflammatory medicines.
Have suffered attacks of asthma, bronchospasm, acute rhinitis, nasal polyps,
urticaria, angioedema (swollen face, eyes, lips, or tongue, or difficulty in breathing),
after taking aspirin or other non-steroidal anti-inflammatory medicines.
Have or have previously suffered from a peptic ulcer or chronic gastro-intestinal
disorders.
Have had previously gastro-intestinal haemorrhage (bleeding).
Have suffered from bronchial asthma.
Have severe heart failure, moderate to severe renal dysfunction or severely
impaired hepatic function.
21
Have a bleeding disorder, a blood clotting disorder or taking an anticoagulant.
Pregnant or breast-feeding.
Dosage And Administration
The dose of Dexketoprofen is 12.5 mg every 4-6 hours daily or 25 mg every 8 hours
daily. The maximum dose is 75 mg daily. For elderly people maximum dose is 50
mg daily. Not recommended for children.
Precautions
The medicine should be used with caution in conditions mentioned below
Allergic to any other medicines.
Kidney disease, liver disease, heart disease or fluid retention conditions.
Blood disorder, systemic lupus erythematosus or mixed connective tissue disease.
Side Effects
As with all medicines, Dexketoprofen may cause some unwanted effects in some
patients. These are described below and are characteristic of non steroidal anti-
inflammatory drugs:
Common (1 - 10%): nausea, vomiting, diarrhoea, stomach pain or heartburn.
Uncommon (0.1 - 1%): sleep disorders, nervousness, headache, dizziness,vertigo,
palpitations, constipation, dry mouth, flatulence, skin rash, fatigue, hot flushes,
shivering, general malaise.
Rare (0.01-0.1%): stomach ulceration, gastric haemorrhage or perforation, pins and
needles, high blood pressure, water retention, slowed breathing rate, increased
hepatic enzymes, increased sweating.
Very rare / isolated cases (<0.01%): blurred vision, ringing in the ear, low blood
pressure, haematological reactions, hepatic or renal damage, dermatological and
photosensitivity reactions, bronchospasm or anaphylaxis.
22
In patients with systemic lupus erythematosus or mixed connective tissue disease,
anti-inflammatory medicines may rarely cause isolated cases of fever, headache
and rigidity of the nape (back of the neck).
Use in pregnancy & lactation
Do not use during pregnancy or breast-feeding.
Use in children
Should not be given to children.
Commercial Pack
Actidex : Each box contains 5 blister strips of 10 Tablets.;
Celenta
Celecoxib 100 & 200 mg capsule
Presentation
Celenta 100 : Each capsule contains Celecoxib INN 100 mg.
Celenta 200 : Each capsule contains Celecoxib INN 200 mg.
23
Description
Celenta is a non-steroidal anti-inflammatory agent (specific COX-2 inhibitor) having
marked anti-inflammatory, analgesic and antipyretic activities with lower incidence
of gastrointestinal adverse effects.
Indications and Uses
Celenta capsule is indicated for the relief of pain and inflammation of osteoarthritis
and adult rheumatoid arthritis. Celenta is also indicated to reduce the number of
adenomatous colorectal polyps in familial adenomatous polyposis (FAP); as an
adjunct to usual care (e.g. endoscopic surveillance, surgery).
Contraindications
Celecoxib is contraindicated in patients with known hypersensitivity to Celecoxib,
who have demonstrated allergic type reactions to sulfonamide or who have
experienced asthma, urticaria or allergic type reactions after taking aspirin or other
NSAIDs.
Dosage And Administration
For osteoarthritis and rheumatoid arthritis, the lowest dose of Celenta should be
sought for each patient. These doses can be given without regard to timing of
meals.
Osteoarthritis: For relief of the signs and symptoms of osteoarthritis the
recommended oral dose is 200 mg per day as a single dose or as 100 mg twice
daily. Rheumatoid arthritis: For relief of the signs and symptoms of rheumatoid
arthiritis the recommended oral dose is 100-200 mg twice daily. Familial
adenomatous polyposis: Usual medical care for FAP patients should be continued
while on Celenta capsules. To reduce the number of adenomatous colorectal polyps
in patients with FAP, the recommended oral dose is 400 mg twice daily to be taken
with food. Hepatic insufficiency: The daily recommended dose of Celenta capsules
in patients with moderate hepatic impairment should be reduced approximately by
50%.
24
Precautions
Celecoxib cannot be expected to substitute for corticosteroids or to treat
corticosteroid insufficiency. Patients on prolonged corticosteroid therapy should
have their therapy tapered slowly if a decision is made to discontinue
corticosteroids. Celecoxib should be prescribed with extreme caution in patients
with a prior history of G.I. ulcer-disease or G.I. bleeding, hepatic and renal
insufficiency, heart failure, those taking diuretics and ACE inhibitors, pre-existing
asthma, elderly patients.
Side Effects
Gastrointestinal side effects include abdominal pain, diarrhea, dyspepsia, flatulence
and nausea. Central nervous system side effects include dizziness, headache and
insomnia. Other side effects include upper respiratory tract infection, skin rash,
back pain and peripheral edema.
Use in pregnancy & lactation
Celecoxib should be used during pregnancy only if the potential benefit justifies the
potential risk to fetus. But in late pregnancy Celecoxib should be avoided because it
may cause premature closure of ductus arteriosus. It is not known whether
Celecoxib is excreted in human milk. Because many drugs are excreted in human
milk and because of potential for serious adverse reactions in nursing infants from
Celecoxib, a decision should be made whether to discontinue nursing or to
discontinue the drug, taking into account the importance of the drug to the mother.
Overdosage
Patients should be managed by symptomatic and supportive care following an
NSAID overdose. There are no specific antidotes. No information is available
regarding the removal of Celecoxib by hemodialysis but based on its high degree of
plasma protein binding (>97%) dialysis is unlikely to be useful in overdose. Emesis
and/or activated charcoal and/or osmotic cathartic may be indicated in patients
seen within 4 hours of ingestion with symptoms or following a large overdose.
Forced diuresis, alkalinization of urine, hemodialysis or hemoperfusion may not be
useful due to high protein binding.
25
Commercial Pack
Celenta 100 : Box containing 5 blister strips of 10 capsules.
Celenta 200 : Box containing 4 blister strips of 10 capsules.;
3.4 Production facilities
The production site comprises of six different multi-storied buildings, which provide
areas for the production of pharmaceutical products. Cephalosporin and general
products are manufactured in those buildings, Cephalosporin facility is physically
separated from other areas.
Manufacturing and packaging operations are carried out according to the
validated methods through systematically qualified machines with full
documentation at all stages of operations. The production sites follow the
cGMP guidelines for environmental requirements of the manufacturing and
packaging area, as well as comply with the EHS requirements. Highly
sophisticated HVAC systems are used to condition, monitor and supply
clean air to the working zone according to the manufacturing zone concept,
capture and control any dust, vapor, gas or fume generated, as well as
treatment of re circulated and/or exhausted air. Temperature and moisture
level are maintained at the desired level through this system.
3.5 Equipment facilities for R & D
26
Incepta has a separate galenical laboratory for R & D, equipped with all necessary
machineries & equipments of GMP standard. Analytical development is supported
by their Quality Control Department. Quality Control Department is equipped with
highly sophisticated instruments like HPLC, Gas Chromatography, Atomic absorption
spectrophotometer, FTIR, etc. A dedicated team is involved in the development and
validation of methods of API, raw materials & finished products. Their R & D team
has pioneered the technology development and subsequent introduction of 53 new
products for the first time in Bangladesh market (up to June 2004). Following are a
few of this long list of
Losartan Potassium tablet
Pantoprazole Sodium delayed release tablet
Loratadine melt in the mouth (Flash) tablet
Verapamil hydrochloride SR tablet
Calcium with Vitamin C effervescent tablet
Multivitamin with multi-mineral tablet which contains 32 Vitamins &
minerals.
3.6 Pricing and promotion
For pricing and promotion Incepta always try to be ahead from their competitors.
The organization always thinks that if they take less money for their medicines then
they will be able to stay in market in a demanding position.
27
Chapter Four
Accounting and finance
Owners of the company have invested a bulk amount of money at the starting of
the company which is used to be capital.
Incepta Pharmaceuticals Ltd., one of the leading pharmaceuticals companies in
Bangladesh has recently availed long-term financing of USD 12.5 million from the
German development finance institution. Citibank, N.A. Bangladesh played the role
of Arranger in the transaction.
Issuing share is one the major ways for being financed of this company. Two times
in the year Incepta sells their shares in the market. Many shareholders are got
interested to get a satisfaction amount of share.
So far arranging money has not been a problem for this company.
Success
In accordance with the financial support they made a glorious performance in the
medicine industry. For instance they got European GMP (Good Manufacturing
Practice) award. It will create a new era in exporting pharmaceutical products.
The pharmaceutical industry has created tremendous potentiality to earn foreign
currency. He assured all the possible assistances from the Government to add
muscle in this particular sector.
The program started with the welcome speech of Mr. Abdul Muktadir, Managing
Director of Incepta Pharmaceuticals Ltd. Besides Mr. Charles Whitley, Charge D’
Affairs of European Commission, Brig. Gen. Sarker M A Matin, Director, Directorate
of Drug Administration, Mr. S M Shafiuzzaman, President, Bangladesh Association of
Pharmaceuticals Industries, Austrian pharmaceutical marketing specialist Mr. Joerg
Kloppert also delivered their speech.28
The Incepta has earned remarkable goodwill both home and abroad in
manufacturing high quality medicine. On this succession the achievement of this
GMP certificate from European Commission has created new possibilities. The
respect and position of local pharmaceutical industry will enhance to a great extent
internationally by this achievement and the scope of exporting will be higher than
ever before.
To mention, by exporting in 19 countries, Incepta is not only bringing fame for the
country, but also contributing remarkably in the development of national economy
by earning foreign remittance. Incepta Pharmaceuticals Ltd. received accreditation
with the European GMP certification on 11th January this year which will allow the
company to export in all the countries of European Union and this certification is
first ever for any local company. Incepta always try to contribute as much as they
can to keep the inflation rate in the satisfactory mood.
29
Incepta Pharmaceuticals Ltd received the Enterprise of the Year 2004 Award while
Selina Quader received the award for Outstanding Woman in Business of the Year
2004. Two giant screens displayed their exemplary successes in brief. Receiving the
Enterprise of the Year 2004 Award on behalf of Incepta Pharmaceuticals Ltd, its
Managing Director Abdul Muktadir said his company is a research-based
pharmaceuticals company and has achieved unprecedented growth in the recent
years. Expressing her reaction to winning the Outstanding Woman in Business of
the Year 2004 Award, Agroconcern Proprietor Selina Quader said it was the first
recognition of her endeavors. She was sure the award would encourage more
women to enter the world of businesse Year 2004, said his company deals with
around 60,000 farmers of the country.
30
Profit & loss account of Incepta Pharmaceutical for last two years
Details Dec 06 Dec 07
Sales Turnover 1,240.62 1,429.97
Excise Duty 101.34 122.09
Net Salessw 1,139.28 1,307.88
Other Income 24.55 31.67
Stock Adjustments 1.45 27.34
Total Income 1,165.28 1,366.89
Expenditure
Raw Materials 387.58 471.61
Power & Fuel Cost 29.93 30.44
Employee Cost 136.38 154.94
Other Manufacturing
Expenses
102.47 113.41
Selling and Admin Expenses 247.48 270.50
Miscellaneous Expenses 23.92 32.03
Total Expenses 927.76 1,072.93
Operating profit 212.97 262.2
PBDIT 237.52 293.96
Interest 3.53 4.61
PBDT 233.99 289.35
Depreciaqtion 42.71 43.49
Other Written Off 0.00 0.00
Profit Before Tax 191.28 245.86
Extra-ordinary items 0.03 0.02
Tax 191.31 245.88
Reported Net Profit 63.66 82.46
Total Value Addition 126.93 162.68
Preference dividend 540.17 601.32
Equity dividend 0.00 0.00
Corporate dividend tax 42.06 50.47
31
Per share data (annualized)
Shares in issues (lakhs) 5.90 8.58
Earnings per share 420.56 420.56
Equity dividend % 30.18 38.68
Book value 3.53 4.61
Chapter Five
Business environment
Environment means the inter-relationship existing between water, air, soil and
physical property and their relationship with human beings, other animals, plants
and micro-organisms. To continue a business an organization has no right to pollute
the environment. There are various kinds of pollution. Such as: air pollution, water
pollution, noise pollution etc.
5.1 Air pollution
Air pollution occurs when the air contains gases, dust, fumes or odor in harmful
amounts. That is, amounts which could be harmful to the health or comfort of
32
humans and animals or which could cause damage to plants and materials. The
substances that cause air pollution are called pollutants. Pollutants that are pumped
into our atmosphere and directly pollute the air are called primary pollutants.
Primary pollutant examples include carbon monoxide from industry exhausts and
sulfur dioxide from the combustion of coal.
Further pollution can arise if primary pollutants in the atmosphere undergo chemical
reactions. The resulting compounds are called secondary pollutants. Photochemical
smog is an example of this.
Incepta Pharmaceuticals always try to avoid the pollution when they make their
products. Incepta use those materials which is not harmful for air.
5.2 Water pollution
Water pollution is the contamination of water bodies such as lakes, rivers, oceans,
and groundwater caused by human activities, which can be harmful to organisms
and plants that live in these water bodies. It occurs when pollutants are discharged
directly into water bodies without treating it first.
To avoid water pollution Incepta never dump their wastage in to the lakes, rivers or
ponds.
33
As Incepta is a medicine produced company, it has some ethical issues which it has
to maintain.
5.3 Not to mix up forbidden materials in medicine
Incepta cannot produce any medicine with the help of bad or rotten ingredients
because this may cause sufferings to the human being even it can cause death to
consumers. It will create a bad image of the company in the market. As a result
government will ban that particular product as well as my company. For this reason
Incepta always suggest their labour to purify the raw materials of the medicine at
every stage.
5.4 Not to sale expired products
As Incepta is a medicine producing company so they have no right to sell any kind
of expired medicine by which the consumers can suffer in a long run for their
health. If they take this kind of steps they will be punished by the law of Bangladesh
Government. By selling expired products the demand of customers will be
decreased. Incepta always remain concerned about this thought. Incepta dispose
the expired items before it reach to the customers.
5.5 Social corporate responsibility
Incepta achieved its tremendous commercial success through its honesty and
sincerity in business policies. The company aims to become nation’s most admired
company through their honest and intelligent approach to everything they do.
Company management strives to support this nation as far as possible in times of
need. Incepta believes it can survive commercially and grow if the nation remains
healthy. Incepta gives emphasis to its practice of CSR and evidence of this
commitment is found in its dealing with customers, suppliers, employees,
Government and the society at large.
34
Company CSR activity includes its finance because the company pays tax and VAT
to the Government and also settles bank and suppliers liabilities in a timely fashion
and disburses benefits to employees on time. Incepta considers its employees to be
valuable assets and protects their rights and provides a full range of staff facilities
including life insurance and disbursement of 5% of the company profit to them.
Incepta maximizes safety in work place for its employees and child labour is strictly
prohibited.
As its commitment to society the company donates medicine to the Government
Relief Fund during natural disaster. Incepta also provides financial assistance for ex
pensive treatment including heart and cancer and disburses its corporate Zakat for
relief of distressed people every year.
Incepta also produces life-saving ‘import substitute medicines’ at affordable price
for the people of Bangladesh as an expression of a true love and compassion for the
people. All these activities are evidence of a socially responsible and caring
company.
Conclusion
Incepta is a fast growing Pharmaceutical company. Incepta develops, manufactures
and markets medicines to address the unmet medical needs of Bangladesh market.
Now Incepta has gone beyond the boundaries of Bangladesh. The company devotes
35
extensive efforts to increase access to medicines through far reaching distribution
network that helps deliver them to the people even in most remote areas. Incepta
always try to providing access to safe, effective and affordable medicines and
related health care services to the people who need them. Incepta is managed and
lead by a dedicated and highly qualified team of doctors, pharmacists, accountants,
analytical chemist, engineer and strong sales force. As a company, Incepta seek to
maintain high ethical standards and culture that values honesty, integrity and
transparency in all levels.
Recommendations
After making the report we found a problem about Incepta Pharmaceuticals that,
the numbers of their branches in all over Bangladesh are too little. If Incepta will
36
increase their branches in all over Bangladesh then it will be helpful to improve their
condition in business market.
Glossary
1. Branch: This is the specific outlet of Standard Chartered Bank that a person
visits to attain services such as cash/cheque deposit/withdrawal, account
opening/closing etc.
37
2. Customers: These include both account and non-account holders of Standard
Chartered Bank who visit our branches to avail a specific service.
3. Zakat: This is an Islamic rule and under this rules almost every Muslim’s have to
give some money to the poor person which is basis on their main income.
38